Research publications from the PsoProtect study group.

Publications

  1. Factors associated with adverse COVID-19 outcomes – insights from a global registry-based study. J Allergy Clin Immunology; https://www.jacionline.org/article/S0091-6749(20)31413-5/fulltext
  2. Risk mitigating behaviours in people with inflammatory skin and joint disease during the COVID-19 pandemic differ by treatment type: a cross-sectional patient survey. Br J Dermatol; https://onlinelibrary.wiley.com/doi/10.1111/bjd.19755
  3. Global reporting of cases of COVID-19 in psoriasis and atopic dermatitis: an opportunity to inform care during a pandemic. Br J Dermatol; https://onlinelibrary.wiley.com/doi/10.1111/bjd.19161
  4. International collaboration and rapid harmonization across dermatologic COVID-19 registries. J Am Acad Dermatol; https://doi.org/10.1016/j.jaad.2020.06.050

Infographics

Infographic showing the impact of COVID-19 in People with Psoriasis Taking Drugs that Affect the Immune System.
Shielding Infographic